Home > Drug Search >
  • Targets: AMP-activated protein kinase (AMPK)
  •   > 
Drug Filter
Status:
Approved (1) Withdrawn (1) Phase Ⅲ (3) Phase Ⅱ (4) Phase Ⅰ (4)
Clinical Stage:
Active (8) Discontinued (3)
Company:
Merck Sharp & Dohme (1) National Cancer Institute (1) Pfizer (1) Unknown (1) Rigel (1) Silanes (1) Esperion (1) Minneamrita Therapeutics (1) Poxel (1) Kareus Therapeutics (1) Betagenon (1) Akaal Pharma (1) Peking University Health Science Center (1) Bristol-Myers Squibb (1)
Indication:
Chronic lymphocytic leukemia (CLL) (2) Diabetic nephropathy (1) Gastric cancer (1) Hypercholesterolemia (1) Hypertension (1) Mantle cell lymphoma (MCL) (1) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Pancreatic cancer (1) Peripheral arterial disease (PAD) (1) Type 2 diabetes (6) Intermittent claudication (1) Plaque psoriasis (1) Insulin resistance (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top